Search

Your search keyword '"Hôpital Le Lamentin Bourg [CHU de la Martinique]"' showing total 4 results
Start Over Author "Hôpital Le Lamentin Bourg [CHU de la Martinique]"
4 results on '"Hôpital Le Lamentin Bourg [CHU de la Martinique]"'

1. Global molecular analysis and APOE mutations in a cohort of autosomal dominant hypercholesterolemia patients in France

Author

Pierre Kieffer, Jean-Philippe Girardet, Khaldia Belabbas, Anne Lienhardt, Ahlam Azar-Kolakez, François Labarthe, Anne-Marie Colin Gorsky, Olivier Lascols, Béatrice Dubern, Franck Boccara, Catherine Tamarindi, Mathilde Di Filippo, Jean-Claude Carel, Félicien MBou, Alice Horovitz, René Wintjens, Dominique Bozon, Mathilde Jolly, Fabienne Dufernez, Ariel Cohen, François Feillet, Patrick Tounian, A. Karsenty, Université Libre de Bruxelles [Bruxelles] (ULB), Centre de Biologie et Pathologie Est (CBPE), Hospices Civils de Lyon (HCL)-Centre National de Référence des Légionelles, Laboratoire Commun de Biologie et Génétiques Moléculaires (LCBGM [Hôpital Saint-Antoine]), AP-HP - Hôpital Saint-Antoine, Service d’Endocrinologie [Hôpital le Lamentin Bourg - CHU de la Martinique], CHU de la Martinique [Fort de France]-Hôpital Le Lamentin Bourg [CHU de la Martinique], CHU de la Martinique [Fort de France], Service de Gastroentérologie et Nutrition Pédiatrique [APHP Trousseau], CHU Trousseau [APHP], Service d'Endocrinologie, Diabétologie et Nutrition [CHU Angers], Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM)-PRES Université Nantes Angers Le Mans (UNAM), Service de Cardiologie [CHU Saint-Antoine], Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-CHU Saint-Antoine [APHP], Service d'endocrinologie diabétologie pédiatrique [CHU Debré], AP-HP Hôpital universitaire Robert-Debré [Paris], Centre de Référence des Maladies Endocriniennes Rares de la Croissance [APHP Robert Debré], Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Hôpital Robert Debré-Université Paris Diderot - Paris 7 (UPD7), Nutrition-Génétique et Exposition aux Risques Environnementaux (NGERE), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Service de Médecine Infantile III et Génétique Clinique [CHRU Nancy], Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy), Nutrition, croissance et cancer (U 1069) (N2C), Université de Tours-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de médecine pédiatrique [CHRU Tours-Clocheville], Centre Hospitalier Régional Universitaire de Tours (CHRU TOURS), Centre Hospitalier d'Argenteuil, Service de Cardiologie [CHU Bordeaux], CHU Bordeaux [Bordeaux], Service de Maternité [CHU Hagueneau], Centre Hospitalier Hagueneau (CH Hagueneau), Service de Médecine Interne [CH Mulhouse- E. Muller], Centre Hospitalier Emile Muller [Mulhouse] (CH E.Muller Mulhouse), Groupe Hospitalier de Territoire Haute Alsace (GHTHA)-Groupe Hospitalier de Territoire Haute Alsace (GHTHA), Service de Pédiatrie médicale - Spécialités médicales [CHU Limoges], CHU Limoges, Université Pierre et Marie Curie - Paris 6 - UFR de Médecine Pierre et Marie Curie (UPMC), Université Pierre et Marie Curie - Paris 6 (UPMC), Cardiovasculaire, métabolisme, diabétologie et nutrition (CarMeN), Institut National de la Recherche Agronomique (INRA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hospices Civils de Lyon (HCL), Université libre de Bruxelles (ULB), CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Robert Debré-Université Paris Diderot - Paris 7 (UPD7), Université de Tours (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Victor Dupouy, Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM), Biology-Imaging District of East-Hospitals Group of AP-HP (Assistance Publique-Hopitaux de Paris), Université de Lorraine (UL)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Tours, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Université Paris Diderot - Paris 7 (UPD7)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Robert Debré, Institut National des Sciences Appliquées (INSA)-Université de Lyon-Institut National des Sciences Appliquées (INSA)-Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Régional Universitaire de Tours (CHRU Tours), Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Institut National des Sciences Appliquées (INSA)-Université de Lyon-Institut National des Sciences Appliquées (INSA)-Université de Lyon-Université Claude Bernard Lyon 1 (UCBL), and Université de Lyon-Institut National de la Recherche Agronomique (INRA)

Subjects
Male, Models, Molecular, Protein Conformation, alpha-Helical, 0301 basic medicine, Apolipoprotein E, Genotyping Techniques, Apolipoprotein B, Familial hypercholesterolemia, apolipoprotéine, 030204 cardiovascular system & hematology, medicine.disease_cause, Biochemistry, Cohort Studies, Exon, 0302 clinical medicine, Endocrinology, Child, apolipoprotein E, Genetics, Mutation, familial hypercholesterolemia, biology, cholestérol, Exons, [SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism, Endocrinologie, 3. Good health, phénotype, Phenotype, Kexin, Female, lipids (amino acids, peptides, and proteins), France, Proprotein Convertase 9, génotype, corrélation, Adult, Biochimie, hypercholestérolemie, QD415-436, Hyperlipoproteinemia Type II, Young Adult, 03 medical and health sciences, Apolipoproteins E, apolipoproteins, cholesterol, low density lipoprotein, phenotype/genotype correlation, medicine, Humans, Apolipoproteins B, PCSK9, Cell Biology, medicine.disease, 030104 developmental biology, Receptors, LDL, [SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human genetics, LDL receptor, biology.protein, Biologie cellulaire, Patient-Oriented and Epidemiological Research
Abstract

Autosomal dominant hypercholesterolemia (ADH) is a human disorder characterized phenotypically by isolated high-cholesterol levels. Mutations in the low density lipoprotein receptor ( LDLR ), APOB, and proprotein convertase subtilisin/kexin type 9 ( PCSK9 ) genes are well known to be associated with the disease. To characterize the genetic background associated with ADH in France, the three ADHassociated genes were sequenced in a cohort of 120 children and 109 adult patients. Fifty-one percent of the cohort had a possible deleterious variant in LDLR, 3.1% in APOB, and 1.7% in PCSK9. We identifi ed 18 new variants in LDLR and 2 in PCSK9. Three LDLR variants, including two newly identifi ed, were studied by minigene reporter assay confi rming the predicted effects on splicing. Additionally, as recently an in-frame deletion in the APOE gene was found to be linked to ADH, the sequencing of this latter gene was performed in patients without a deleterious variant in the three former genes. An APOE variant was identifi ed in three patients with isolated severe hypercholesterolemia giving a frequency of 1.3% in the cohort. Therefore, even though LDLR mutations are the major cause of ADH with a large mutation spectrum, APOE variants were found to be signifi-cantly associated with the disease. Furthermore, using structural analysis and modeling, the identifi ed APOE sequence changes were predicted to impact protein function., SCOPUS: ar.j, info:eu-repo/semantics/published

Published
2016
Full Text
View/download PDF

2. The French National Cochlear Implant Registry (EPIIC): Cochlear explantation and reimplantation

Author

Isabelle Mosnier, Stéphane Roman, A. Bozorg-Grayeli, Y. Lerosey, Valérie Franco-Vidal, K. Mezouaghi, R. Marianowski, P. Piller, N. Klopp, C. Vincent, Alexandre Karkas, Natalie Loundon, Nicolas Guevara, T. Mom, Olivier Deguine, K. Aubry, Emmanuel Lescanne, S. Roux-Vaillard, Benoit Godey, L. Tavernier, C. Eyermann, Cécile Parietti-Winkler, R Hermann, F. Merklen, M. Labrousse, Sébastien Schmerber, Eric Truy, S. Moreau, J.-P. Lebreton, N. Noël-Petroff, E. Radafy, A. Coudert, C. Poncet, Philippe Bordure, Equipe IFTIM [ImViA - EA7535], Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon)-Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] (UNICANCER/CRLCC-CGFL), UNICANCER-UNICANCER-Imagerie et Vision Artificielle [Dijon] (ImViA), Université de Bourgogne (UB)-Université de Bourgogne (UB), Institut de Neurosciences des Systèmes (INS), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Lille, Inserm, CHU Lille, Hôpital Edouard Herriot [CHU - HCL], Service d'Oto-rhino-laryngologie (ORL) et chirurgie cervico-faciale [CHU Limoges], Centre hospitalier universitaire de Nantes [CHU Nantes], Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand [CHU Dijon], Centre Hospitalier Universitaire de Toulouse [CHU Toulouse], CHU Strasbourg, CHU Bordeaux [Bordeaux], CHU Pontchaillou [Rennes], Hôpital Pasteur [Nice] [CHU], Centre Hospitalier Universitaire de Saint-Etienne [CHU Saint-Etienne] [CHU ST-E], CHU Amiens-Picardie, Centre Hospitalier Universitaire de Reims [CHU Reims], Centre hospitalier universitaire de Poitiers [CHU Poitiers], CHU Rouen, CHU Trousseau [Tours], CHU Necker - Enfants Malades [AP-HP], Hôpital Morvan - CHRU de Brest [CHU - BREST ], Service ORL [Hôpital Gui de Chauliac] [CHRU de Montpellier], Centre Hospitalier Universitaire de La Réunion [CHU La Réunion], CHU Gabriel Montpied [Clermont-Ferrand], CHU Caen, CHU Pitié-Salpêtrière [AP-HP], Hôpital Robert Debré Paris, Hôpital Le Lamentin Bourg [CHU de la Martinique], CHU Marseille, Centre Hospitalier Universitaire d'Angers [CHU Angers], CHU Grenoble, Centre Hospitalier Régional Universitaire de Besançon [CHRU Besançon], and Médicaments et biomatériaux à libération contrôlée: mécanismes et optimisation - Advanced Drug Delivery Systems - U 1008 [MBLC - ADDS]

Subjects
Adult, Reoperation, medicine.medical_specialty, Time Factors, Adolescent, medicine.medical_treatment, [SDV]Life Sciences [q-bio], Young Adult, 03 medical and health sciences, 0302 clinical medicine, Cochlear implant, medicine, Humans, Prospective Studies, Registries, Child, 030223 otorhinolaryngology, Cochlear implantation, Prospective cohort study, Device Removal, ComputingMilieux_MISCELLANEOUS, Aged, Aged, 80 and over, business.industry, Age Factors, Infant, Registry, Reimplantation, Explantation, Middle Aged, Cochlear Implantation, Prosthesis Failure, 3. Good health, Surgery, Cochlear Implants, Otorhinolaryngology, Child, Preschool, Replantation, 030220 oncology & carcinogenesis, France, Implant, business, Pediatric population
Abstract

This study aims to determine the frequency and causes of cochlear explants with re-implantation (ERI) after 5 years’ follow up of the patients included in the French national EPIIC (étude post-inscription des implants cochléaires) registry tracking patients with cochlear implantation. This multicenter, descriptive prospective study was conducted on 5051 patients enrolled in the EPIIC database between January 2012 and December 2016. Ninety-five patients (1.9%) received a primary implant and an ERI during the study. Of these, four benefitted from two ERIs. The number of ERIs was significantly higher in the pediatric population than among adults. The explantation and reimplantation were performed simultaneously in 86% of cases. The reasons for explantation were: in 46.4% of cases linked to a malfunction of the implant, and in 39.3% of cases for medical or surgical reasons. The number of electrodes inserted was significantly higher after the ERI than after the first implantation. There was just one post-ERI infection for these 95 explanted and re-implanted patients. As well as explantation with reimplantation rarely being necessary, it generally presents no major surgical difficulty and in most cases it allows a better integration than in the first implantation. 137;Supplement 1

Published
2020
Full Text
View/download PDF

3. Guillain-Barré Syndrome Associated With Zika Virus Infection in Martinique in 2016: A Prospective Study

Author

Benoît, Rozé, Fatiha, Najioullah, Jean-Louis, Fergé, Frédérique, Dorléans, Kossivi, Apetse, Jose-Luis, Barnay, Elise, Daudens-Vaysse, Yannick, Brouste, Raymond, Césaire, Laurence, Fagour, Ruddy, Valentino, Martine, Ledrans, Hossein, Mehdaoui, Sylvie, Abel, Isabelle, Leparc-Goffart, Aissatou, Signate, André, Cabié, Rosalie, Vilain, Service de Maladies Infectieuses et Tropicales [Fort-de-France, Martinique], CHU Fort de France-CHU de la Martinique [Fort de France]-Hôpital Pierre Zobda-Quitman [CHU de la Martinique], CHU de la Martinique [Fort de France], Unité de soins intensifs [CHU Martinique], Hôpital Pierre Zobda-Quitman [CHU de la Martinique], CHU de la Martinique [Fort de France]-CHU de la Martinique [Fort de France], Laboratoire de Virologie-Immunologie [Fort de France, Martinique] (EA 4537), Centre Hospitalier Universitaire de Martinique [Fort-de-France, Martinique], Unité Régionale Antilles Guyane [Saint-Maurice] (Agence Nationale de la Santé Publique ), Département d'Electrophysiologie [Fort de France, Martinique], Unité de Réhabilitation [Fort de France, Martinique], Hôpital Le Lamentin Bourg [CHU de la Martinique], Service d'Urgence [Fort de France, Martinique], Institut de Recherche Biomédicale des Armées [Antenne Marseille] (IRBA), Environnement, Santé, Sociétés (ESS), Centre National de la Recherche Scientifique (CNRS), Service de neurologie [Fort-de-France, Martinique], CHU de la Martinique [Fort de France]-Hôpital Pierre Zobda-Quitman [CHU de la Martinique], CHU de la Martinique [Fort de France]-Centre Hospitalier Universitaire de Martinique [Fort-de-France, Martinique], Centre d'Investigation Clinique Antilles-Guyane (CIC - Antilles Guyane), CHU de Fort de France-Centre Hospitalier Andrée Rosemon [Cayenne, Guyane Française]-CHU Pointe-à-Pitre/Abymes [Guadeloupe] -Institut National de la Santé et de la Recherche Médicale (INSERM)-Université des Antilles et de la Guyane (UAG), This research was sponsored by University Hospital of Martinique (UHM) for regulatory and ethic submission and supported by the Clinical Research Hospital Program from the French Ministry of Health (PHRC 2009, NCT01099852). This research was support by the French network for Research and Action targeting emerging infectious diseases (REACTING)., Guillain-Barré Syndrome Zika Working Group of Martiniquea : Gwenole Jean Abgrall, Véronique Aïm, Alessandro Arrigo, Philippe Cabre, Cyrille Chabartier, Sylvie Colombani, Julien Cuziat, Christophe Deligny, Nicole Desbois, Anne-Laure Dessoy, Gaëlle Dunoyer, Régis Duvauferrier, N’Guyen Duc, Mireille Edimonana, Pierre Garrigou, Stéphane Gaucher, Sarah Gourgoudou, Karine Guitteaud, Patrick Hochedez, Gwladys Ivanes, Yolène Jacquens, Sandrine Julié, Armelle Jean-Etienne, Séverine Jeannin, Joux Julien, Pasquier Jérémie, Jean- Louis Lamaignère, Ingrid Laudarin, Maud Le Gall, Véronique Legris- Allusson, Mehdi Mejdoubi, Corinne Michel, Franck Michel, Charline Miossec, Florence Moinet, Cervantes Minerva, Claude Olive, Pascale Olive, Karine Pailla, Céline Paysant, Sandrine Pierre-François, Mathilde Pircher, Katlyne Polomat, Alain Putot, Patrick René-Corail, Dabor Resiere, Christiane Richer, Jean-Romain Risson, Karen Rome, Marie Sabia, Michel Schloesser, Pauline Simonnet-Vigeral, Rafaelle Théodose, Rosalie Vilain., Université des Antilles et de la Guyane (UAG)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pointe-à-Pitre/Abymes [Guadeloupe] -CHU de Fort de France-Centre Hospitalier Andrée Rosemon [Cayenne, Guyane Française], and BUISINE, Soline

Subjects
Microbiology (medical), Male, Pediatrics, medicine.medical_specialty, 030231 tropical medicine, Guillain-Barre Syndrome, Zika virus, Serology, Disease Outbreaks, 03 medical and health sciences, 0302 clinical medicine, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Intensive care, Medicine, Humans, Martinique, Prospective Studies, Aged, [SDV.MP.VIR] Life Sciences [q-bio]/Microbiology and Parasitology/Virology, [SDV.MHEP.ME] Life Sciences [q-bio]/Human health and pathology/Emerging diseases, [SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases, biology, Guillain-Barre syndrome, business.industry, Outbreak, Retrospective cohort study, vector-borne infections, Zika Virus, Middle Aged, Zika virus infection, biology.organism_classification, medicine.disease, bacterial infections and mycoses, Guillain-Barré syndrome, 3. Good health, Infectious Diseases, outbreaks, [SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology, [SDV.MHEP.MI] Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Etiology, Female, business, 030217 neurology & neurosurgery
Abstract

International audience; Background: Guillain-Barré syndrome (GBS) has been reported to be associated with Zika virus (ZIKV) infection in case reports and retrospective studies, mostly on the basis of serological tests, with the problematic cross-reacting antibodies of the Flavivirus genus. Some GBS cases do not exhibit a high level of diagnostic certainty. This prospective study aimed to describe the clinical profiles and the frequency of GBS associated with ZIKV during the ZIKV outbreak in Martinique in 2016.Methods: We recorded prospective data from GBS meeting levels 1 or 2 of diagnostic certainty for the Brighton Collaboration, with proof of recent ZIKV infection and negative screening for etiologies of GBS.Results: Of the sample of 34 patients with suspected GBS during the outbreak, 30 had a proven presence of GBS, and 23 had a recent ZIKV infection. The estimated GBS incidence rate ratio (2016 vs 2006-2015) was 4.52 (95% confidence interval, 2.80-7.64; P = .0001). Recent ZIKV infection was confirmed by urine reverse-transcription polymerase chain reaction (RT-PCR) analysis in 17 cases and by serology in 6 cases. Patients, 65% of whom were male, had a median age of 61 years (interquartile range, 56-71 years) and experienced severe GBS. Electrophysiological tests were consistent with the primary demyelinating form of the disease.Conclusions: ZIKV infection is usually benign, when symptomatic, but in countries at risk of ZIKV epidemics, adequate intensive care bed capacity is required for management of severe GBS cases. Arbovirus RNA detection by RT-PCR should be part of the management of GBS cases.

Published
2017
Full Text
View/download PDF

4. The challenge of chronic chikungunya

Author

André Cabié, Bernard Alex Gaüzère, Emilie Javelle, Patrick René Corail, Philippe Gautret, Anne Ribera, Fabrice Simon, Département des Maladies infectieuses [Marseille], Hôpital d'instruction des armées Laveran [Marseille], Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes (URMITE), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR48, INSB-INSB-Centre National de la Recherche Scientifique (CNRS), Centre hospitalier Félix-Guyon [Saint-Denis, La Réunion], Unité de Soins Intensifs [CHU La Réunion], Centre Hospitalier Universitaire de La Réunion (CHU La Réunion), Service de Maladies Infectieuses et Tropicales [Fort-de-France, Martinique], CHU de la Martinique [Fort de France]-Hôpital Pierre Zobda-Quitman [CHU de la Martinique], CHU de la Martinique [Fort de France]-Centre Hospitalier Universitaire de Martinique [Fort-de-France, Martinique], Unité de Réhabilitation [Fort de France, Martinique], Hôpital Le Lamentin Bourg [CHU de la Martinique], CHU de la Martinique [Fort de France]-CHU de la Martinique [Fort de France], Centre d'Investigation Clinique Antilles Guyane, Inserm CIC1424, and Institut des sciences biologiques (INSB-CNRS)-Institut des sciences biologiques (INSB-CNRS)-Centre National de la Recherche Scientifique (CNRS)

Subjects
0301 basic medicine, medicine.medical_specialty, Biomedical Research, 030106 microbiology, medicine.disease_cause, Communicable Diseases, Emerging, World health, 03 medical and health sciences, 0302 clinical medicine, Case fatality rate, medicine, Humans, Chikungunya, Intensive care medicine, Socioeconomic status, 030203 arthritis & rheumatology, Chronic stage, business.industry, Public health, Public Health, Environmental and Occupational Health, Tropical disease, virus diseases, Chronic arthritis, medicine.disease, 3. Good health, Infectious Diseases, [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, Immunology, Chronic Disease, Chikungunya Fever, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, business, Chikungunya virus
Abstract

International audience; Since the early 2000's, chikungunya has been considered to be a rapidly expanding, re-emerging, tropical disease. This led the National Institute of Allergy and Infectious Diseases (NIAID) together with the World Health Organization (WHO) to organize an expert consultation in June 2015. At the meeting, the major socioeconomic impact and the large public health burden, due to a high rate of debilitating, chronic arthritis and other co-morbidities, were highlighted. Some evidencewas also found that chikungunya is likely to remain a difficult infection to prevent or control, even when vaccines and effective treatments become available [1]. Thus, regarding the low fatality rate, one major challenge of chikungunya epidemics in coming years will be the management of the chronic stage.

Published
2017
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results